Finance

Lists
600329:SHA
Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CNยฅ38.65
-0.80%
(-0.31) 1D
Nov 17, 3:00:02โ€ฏPM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600329...
Open
CNยฅ39.01
High
CNยฅ39.25
Low
CNยฅ38.33
Mkt. cap
25.59B
Avg. vol.
5.04M
Volume
4.37M
Dividend
12.39%
Quarterly dividend
CNยฅ1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
33.26
52-wk high
CNยฅ49.15
52-wk low
CNยฅ33.83
EPS
CNยฅ1.16
Shares outstanding
568.87M
No. of employees
4K
Open
CNยฅ39.01
High
CNยฅ39.25
Low
CNยฅ38.33
Mkt. cap
25.59B
Avg. vol.
5.04M
Volume
4.37M
Dividend
12.39%
Quarterly dividend
CNยฅ1.20
Ex-dividend date
Jul 10, 2026
P/E ratio
33.26
52-wk high
CNยฅ49.15
52-wk low
CNยฅ33.83
EPS
CNยฅ1.16
Shares outstanding
568.87M
No. of employees
4K
News stories
From web sources and news partners
About Tianjin Pharmcetl Da Ren Tang Grp Cp Ltd
CEO-
Employees3.89K
Founded1915
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
1.25B
1.52B
939.39M
963.22M
Cost of goods sold
394.31M
337.79M
292.96M
247.04M
Cost of revenue
394.31M
337.79M
292.96M
247.04M
Research and development expenses
85.19M
29.81M
50.15M
44.81M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
696.15M
625.03M
371.90M
359.12M
Operating expense
807.49M
677.84M
441.00M
395.50M
Total operating expenses
1.20B
1.02B
733.96M
642.54M
Operating income
45.67M
499.57M
205.42M
320.67M
Other non operating income
1.48M
-450.84K
-152.55K
-10.61M
EBT including unusual items
-32.76M
494.29M
258.05M
308.22M
EBT excluding unusual items
66.32M
529.85M
223.56M
308.22M
Income tax expense
2.71M
71.23M
37.55M
39.06M
Effective tax rate
-8.27%
14.41%
14.55%
12.67%
Other operating expenses
28.38M
20.68M
14.35M
-8.43M
Net income
-21.16M
423.80M
220.94M
272.08M
Net profit margin
-1.70%
27.97%
23.52%
28.25%
Earnings per share
-
-
-
-
Interest and investment income
22.29M
33.73M
20.96M
2.21M
Interest expense
-2.32M
-3.00M
-2.18M
-88.00K
Net interest expenses
19.97M
30.73M
18.79M
2.12M
Depreciation and amortization charges
-
-
-
-
EBITDA
72.82M
526.71M
230.47M
351.17M
Gain or loss from assets sale
-2.83M
-
181.42K
29.00K
Upcoming events
AI content may include mistakes. Learn more
Google apps